BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23992312)

  • 1. The enzymology of cytosolic pyrimidine 5'-nucleotidases: functional analysis and physiopathological implications.
    Magni G; Amici A; Orsomando G
    Curr Med Chem; 2013; 20(34):4304-16. PubMed ID: 23992312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of substrate specificity and selectivity of murine cytosolic 5'-nucleotidase III.
    Grobosky CL; Lopez JB; Rennie S; Skopelitis DJ; Wiest AT; Bingman CA; Bitto E
    J Mol Biol; 2012 Nov; 423(4):540-54. PubMed ID: 22925580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of the novel cytosolic 5'-nucleotidase IIIB explain its preference for m7GMP.
    Monecke T; Buschmann J; Neumann P; Wahle E; Ficner R
    PLoS One; 2014; 9(3):e90915. PubMed ID: 24603684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of soluble 5'-nucleotidases in the conversion of nucleotide analogs: metabolic and therapeutic aspects.
    Składanowski AC
    Curr Med Chem; 2013; 20(34):4249-59. PubMed ID: 23992311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.
    Galmarini CM; Jordheim L; Dumontet C
    Leuk Lymphoma; 2003 Jul; 44(7):1105-11. PubMed ID: 12916861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic properties and physiological roles of cytosolic 5'-nucleotidase II.
    Itoh R
    Curr Med Chem; 2013; 20(34):4260-84. PubMed ID: 23992315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the physiological role of cytosolic 5'-nucleotidase II (cN-II): pathological and therapeutical implications.
    Tozzi MG; Pesi R; Allegrini S
    Curr Med Chem; 2013; 20(34):4285-91. PubMed ID: 23992310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic studies on bovine cytosolic 5'-nucleotidase II, an enzyme belonging to the HAD superfamily.
    Allegrini S; Scaloni A; Careddu MG; Cuccu G; D'Ambrosio C; Pesi R; Camici M; Ferrara L; Tozzi MG
    Eur J Biochem; 2004 Dec; 271(23-24):4881-91. PubMed ID: 15606776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional logic of cytosolic 5'-nucleotidases.
    Ipata PL; Balestri F
    Curr Med Chem; 2013; 20(34):4205-16. PubMed ID: 23992316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional data from two kindreds with genetically induced deficiencies of erythrocyte pyrimidine nucleotidase.
    Paglia DE; Fink K; Valentine WN
    Acta Haematol; 1980; 63(5):262-7. PubMed ID: 6251690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic evidence for covalent phosphoryl-enzyme intermediate in phosphotransferase activity of human red cell pyrimidine nucleotidases.
    Amici A; Emanuelli M; Ruggieri S; Raffaelli N; Magni G
    Methods Enzymol; 2002; 354():149-59. PubMed ID: 12418222
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation and activity of cytosolic 5'-nucleotidase II. A bifunctional allosteric enzyme of the Haloacid Dehalogenase superfamily involved in cellular metabolism.
    Bretonnet AS; Jordheim LP; Dumontet C; Lancelin JM
    FEBS Lett; 2005 Jun; 579(16):3363-8. PubMed ID: 15946667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemolytic anemia due to abnormalities in erythrocyte nucleotide metabolism].
    Masuda M; Mizoguchi H
    Nihon Rinsho; 1996 Sep; 54(9):2473-7. PubMed ID: 8890581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine cytosolic 5'-nucleotidase acts through the formation of an aspartate 52-phosphoenzyme intermediate.
    Allegrini S; Scaloni A; Ferrara L; Pesi R; Pinna P; Sgarrella F; Camici M; Eriksson S; Tozzi MG
    J Biol Chem; 2001 Sep; 276(36):33526-32. PubMed ID: 11432867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic non-spherocytic haemolytic anaemia due to congenital pyrimidine 5' nucleotidase deficiency: 25 years later.
    Vives i Corrons JL
    Baillieres Best Pract Res Clin Haematol; 2000 Mar; 13(1):103-18. PubMed ID: 10916681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary haemolytic anaemia due to red cell pyrimidine 5'-nucleotidase deficiency in two Irish families with a note on the benefit of splenectomy.
    McMahon JN; Lieberman JE; Gordon-Smith EC; Egan EL
    Clin Lab Haematol; 1981; 3(1):27-34. PubMed ID: 6262006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of pyrimidine 5'-nucleotidase deficiency caused by 3 newly identified missense mutations (c.187T>C, c.469G>C and c.740T>C) and a tabulation of known mutations.
    Chiarelli LR; Morera SM; Galizzi A; Fermo E; Zanella A; Valentini G
    Blood Cells Mol Dis; 2008; 40(3):295-301. PubMed ID: 18499901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance.
    Hunsucker SA; Spychala J; Mitchell BS
    J Biol Chem; 2001 Mar; 276(13):10498-504. PubMed ID: 11133996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-bound 5'-nucleotidase/nucleoside phosphotransferase from Bacillus cereus.
    Baiocchi C; Pesi R; Turriani M; Tozzi MG; Camici M; Ipata PL
    Int J Biochem; 1993 Nov; 25(11):1625-9. PubMed ID: 8288031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead poisoning: association with hemolytic anemia, basophilic stippling, erythrocyte pyrimidine 5'-nucleotidase deficiency, and intraerythrocytic accumulation of pyrimidines.
    Valentine WN; Paglia DE; Fink K; Madokoro G
    J Clin Invest; 1976 Oct; 58(4):926-32. PubMed ID: 965496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.